Ilan Yaron
Department of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Front Digit Health. 2020 Dec 3;2:569178. doi: 10.3389/fdgth.2020.569178. eCollection 2020.
Artificial intelligence (AI) digital health systems have drawn much attention over the last decade. However, their implementation into medical practice occurs at a much slower pace than expected. This paper reviews some of the achievements of first-generation AI systems, and the barriers facing their implementation into medical practice. The development of second-generation AI systems is discussed with a focus on overcoming some of these obstacles. Second-generation systems are aimed at focusing on a single subject and on improving patients' clinical outcomes. A personalized closed-loop system designed to improve end-organ function and the patient's response to chronic therapies is presented. The system introduces a platform which implements a personalized therapeutic regimen and introduces quantifiable individualized-variability patterns into its algorithm. The platform is designed to achieve a clinically meaningful endpoint by ensuring that chronic therapies will have sustainable effect while overcoming compensatory mechanisms associated with disease progression and drug resistance. Second-generation systems are expected to assist patients and providers in adopting and implementing of these systems into everyday care.
在过去十年中,人工智能(AI)数字健康系统备受关注。然而,它们在医学实践中的应用速度比预期要慢得多。本文回顾了第一代人工智能系统的一些成就,以及它们在医学实践中应用所面临的障碍。文中讨论了第二代人工智能系统的发展,重点是克服其中一些障碍。第二代系统旨在专注于单一主题并改善患者的临床结局。本文介绍了一个旨在改善终末器官功能和患者对慢性治疗反应的个性化闭环系统。该系统引入了一个实施个性化治疗方案的平台,并将可量化的个体差异模式引入其算法中。该平台旨在通过确保慢性治疗具有可持续效果,同时克服与疾病进展和耐药性相关的代偿机制,从而实现具有临床意义的终点。预计第二代系统将帮助患者和医疗服务提供者在日常护理中采用和实施这些系统。